Australian nuclear medicine company Telix Pharmaceuticals has expanded its theranostic pipeline with new assets targeting Fibroblast Activation Protein. …
Telix announces agreement to add FAP-targeting candidates to theranostic pipeline
November 20, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Telix announces agreement to add FAP-targeting candidates to theranostic pipeline
November 20, 2024 - - Latest News -
GBMA says Australia can benefit from a biosimilar medicines funding windfall
November 20, 2024 - - Latest News -
Ramsay Health Care and Bupa join forces to develop our next generation of nurses
November 19, 2024 - - Other Health -
Moderna appoints new director of regional research centre for respiratory medicines and tropical diseases
November 19, 2024 - - Latest News -
AusBiotech and MTPConnect bring together life sciences sector for national summit
November 19, 2024 - - Latest News -
BMS Australia to host a summit focused on patients and the parliament
November 19, 2024 - - Latest News -
PBAC member and former industry executive appointed to board of local biotech
November 18, 2024 - - Latest News